Kura Oncology (KURA) Receivables - Other (2014 - 2020)
Kura Oncology (KURA) reported Receivables - Other of $31000.0 for Q1 2020, down 82.68% year-over-year from $179000.0 in Q2 2019, and up 3.33% quarter-over-quarter from $30000.0 in Q4 2019.
Kura Oncology (KURA) Receivables - Other (2014 - 2020) Analysis & Trends
Kura Oncology (KURA) has 7 years of Receivables - Other data on file, last reported at $31000.0 in Q1 2020.
- Receivables - Other for Q1 2020 came in at $31000.0, down 82.68% year-over-year; the trailing twelve-month figure through Mar 2020 was $31000.0 (down 82.68% YoY), and the FY2019 annual result was $30000.0, down 86.61% from the prior year.
- Receivables - Other rose to $31000.0 in Q1 2020 per KURA's latest filing, from $30000.0 in the prior quarter.
- Over five years, Receivables - Other peaked at $406000.0 in Q1 2016 and troughed at $30000.0 in Q4 2019.
- A 5-year average of $215235.3 and a median of $230000.0 in 2018 frame the typical range for Receivables - Other.
- The sharpest annual moves came in 2016 and 2019: Receivables - Other increased 16.33% in 2016, then plunged 86.61% in 2019.
- A 5-year view of Receivables - Other shows it stood at $295000.0 in 2016, then dropped by 26.78% to $216000.0 in 2017, then gained by 3.7% to $224000.0 in 2018, then sank by 86.61% to $30000.0 in 2019, then gained by 3.33% to $31000.0 in 2020.
- Business Quant data shows KURA's Receivables - Other at $31000.0 in Q1 2020, $30000.0 in Q4 2019, and $47000.0 in Q3 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Kura Oncology | 883.44 Mn | 883.44 Mn | 18.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2020 | 31,000.00 |
| Mar 31, 2020 | 31,000.00 |
| Dec 31, 2019 | 30,000.00 |
| Dec 31, 2019 | 30,000.00 |
| Sep 30, 2019 | 47,000.00 |
| Sep 30, 2019 | 47,000.00 |
| Jun 30, 2019 | 111,000.00 |
| Jun 30, 2019 | 111,000.00 |
| Mar 31, 2019 | 179,000.00 |
| Mar 31, 2019 | 179,000.00 |
| Dec 31, 2018 | 224,000.00 |
| Dec 31, 2018 | 224,000.00 |
| Sep 30, 2018 | 232,000.00 |
| Sep 30, 2018 | 232,000.00 |
| Jun 30, 2018 | 230,000.00 |
| Jun 30, 2018 | 230,000.00 |
| Mar 31, 2018 | 257,000.00 |
| Mar 31, 2018 | 257,000.00 |
| Dec 31, 2017 | 216,000.00 |
| Dec 31, 2017 | 216,000.00 |